Janover Inc Common Stock (JNVR) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 1,283.7%.
| ASSET | % RETURN |
|---|---|
Janover Inc Common Stock (JNVR) | 1,283.65% |
Oncology Institute (TOI) | 850.98% |
Regencell Bioscience (RGC) | 575.98% |
Global Interactive Technologies (GITS) | 426.97% |
Dominari (DOMH) | 405.47% |
Abits (ABTS) | 354.55% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 339.83% |
CervoMed (CRVO) | 281.25% |
Nutex Health (NUTX) | 271.68% |
Yoshiharu Global (YOSH) | 266.36% |
Upexi (UPXI) | 258.89% |
Oriental Culture Holding (OCG) | 242.86% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 198.94% |
ThredUp (TDUP) | 197.92% |
TMC the metals (TMC) | 190.35% |
Junee Limited Ordinary Shares (JUNE) | 188.75% |
DBV Technologies (DBVT) | 178.72% |
Neuronetics (STIM) | 169.7% |
QuantaSing Group Limited American Depositary Shares (QSG) | 161.99% |
Rapid Micro Biosystems (RPID) | 157.14% |
Vasta Platform (VSTA) | 140.5% |
908 Devices (MASS) | 136.89% |
Microbot Medical (MBOT) | 135.96% |
Curiositystream (CURI) | 135.11% |
Hertz Global (HTZ) | 129.38% |
